Spinal and Paraspinal Plexiform Neurofibromas in Patients with Neurofibromatosis Type 1: A Novel Scoring System for Radiological-Clinical Correlation.

about

Spinal and Paraspinal Plexiform Neurofibromas in Patients with Neurofibromatosis Type 1: A Novel Scoring System for Radiological-Clinical Correlation.

Item

http://www.wikidata.org/entity/Q48256644

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Spinal and Paraspinal Plexifor ...... ological-Clinical Correlation.

@en

Spinal and Paraspinal Plexifor ...... ological-Clinical Correlation.

@nl

type

Item

label

Spinal and Paraspinal Plexifor ...... ological-Clinical Correlation.

@en

Spinal and Paraspinal Plexifor ...... ological-Clinical Correlation.

@nl

prefLabel

Spinal and Paraspinal Plexifor ...... ological-Clinical Correlation.

@en

Spinal and Paraspinal Plexifor ...... ological-Clinical Correlation.

@nl

P1476

Spinal and Paraspinal Plexifor ...... iological-Clinical Correlation

@en

P2093

B Shofty

http://www.w3.org/2001/XMLSchema#string

F Bokstein

http://www.w3.org/2001/XMLSchema#string

L Ben-Sira

http://www.w3.org/2001/XMLSchema#string

M Mauda-Havakuk

http://www.w3.org/2001/XMLSchema#string

S Ben-Shachar

http://www.w3.org/2001/XMLSchema#string

S Constantini

http://www.w3.org/2001/XMLSchema#string

P2860

Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas

Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study.

Clinical characteristics of spinal nerve sheath tumors: analysis of 149 cases.

Neurofibromatosis type 1: spinal manifestations of a systemic disease.

Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas.

Surgical management of cervical spine manifestations of neurofibromatosis Type 1: long-term clinical and radiological follow-up in 22 cases.

Musculoskeletal manifestations of neurofibromatosis type 1.

The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features.

Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas.

Incidence and mortality of neurofibromatosis: a total population study in Finland.

P304

1869-1875

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3174/AJNR.A5338

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28798215

http://www.w3.org/2001/XMLSchema#string